Diligence memo · auto-generated · as of July 2, 2026

MaskZero LLC

MaskZero LLC looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

MaskZero LLC operates in Biotechnology, based in DENVER.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

MaskZero LLC has raised $1.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $1.0M on 2022-09-30.

Most recent recorded round closed around 2022-09-30.

Valuation (modeled)modeled

Provath models MaskZero LLC at approximately $13M (range $727K–$55M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.91× the median modeled value of Seed Biotechnology companies in 2022–2024 (207 peers) — value vs value, same stage and era. Within the normal band (91% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 3.8 yr ago; this sector typically re-raises about every 14 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 19% of Biotechnology peers (4291 compared).

Modeled value ranks above 22% of those peers.

Closest niche peers: Mesentech Inc., Marlinspike Therapeutics, Inc., Microbial Machines, Inc., Pearl Diagnostics, Inc., Crossfire Medical Inc.

Peoplefiled

3 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.